This study aims to test whether sleep improvements, following 6 weeks of high-intensity interval training exercise among adult women exposed to a traumatic event, are mediated by improvements in heart rate variability or decreased anxiety and hyperarousal symptoms.
Registry Overview
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Recruitment status
completed
Actual enrollment (reported)
41 participants
Study completion date
March 31, 2023
Actual (reported)
Listed locations
1 countries · 1 sites
Trial Relationships
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Related Scientific Literature
Loading related publications...
Study Timeline
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
The PSQI consists of 19 items. Scores range from 0-21, higher scores indicate poorer sleep quality. A global score ≥5 indicates poor sleep quality.
Change from Baseline to week 7
Heart Rate Variability
High frequency (HF) and low frequency (LF) domains of heart rate variability will be assessed before, during, and following a cognitive task.
Change from Baseline to Week 7
State Trait Anxiety Inventory (STAI-Y2)
The STAI-Y2 Trait subscale consists of 20-item and will assess anxiety. The total score ranges from 20-80; higher scores indicate greater trait anxiety.
Change from Baseline to Week 7
Study Arms (2)
High Intensity Interval Training (HIIT)
EXPERIMENTAL
High-intensity interval training will be performed three times a week for a total of six weeks.
Behavioral: High Intensity Interval Training (HIIT)
Waitlist Control
SHAM COMPARATOR
Waitlist participants were tested on the outcomes at the same time points as the treatment group (i.e., HIIT). Following completion of the waitlist treatment, participants will be eligible to receive a supervised exercise program (no data will be collected). The waitlist participants formed a no-treatment control group.
Other: Waitlist
Interventions
High Intensity Interval Training (HIIT)Behavioral
Twenty minutes of HIIT will be completed three days a week for six weeks.
High Intensity Interval Training (HIIT)
WaitlistOther
Waitlist participants will be tested on the outcomes at the same time points as the treatment group.
Waitlist Control
Eligibility Criteria
Age18 Years - 39 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
You may qualify if:
self-reported exposure to a traumatic event
persistent (\> 1 month) PTSD-related symptoms adequate to screen positive for PTSD or self-reported history of a prior PTSD diagnosed by a health care professional.
McGranahan MJ, O'Connor PJ. Effect of high-intensity interval training exercise on sleep quality in women with probable post-traumatic stress disorder: A pilot randomized controlled trial. Sleep Med. 2025 May;129:245-256. doi: 10.1016/j.sleep.2025.02.029. Epub 2025 Feb 21.
The PDS-5 consists 24-item scale and will assess PTSD symptoms based on the diagnostic criteria for the DMS-5. The full PDS-5 assesses trauma history, symptom onset, and index of trauma. The total score ranges from 0-80.
Change from Baseline to Week 7
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
poor sleep quality (Pittsburgh Sleep Quality Index \>5)
failure to meet recommended level of aerobic or resistance training during leisure time. Physical activity for U.S. adults (\<150-mins of moderate or 75-mins of vigorous physical activity \[or a combination\] per week and/or \< 2 days a week of resistance training targeting the major muscle groups).
able to safely perform high-intensity exercise
aged 18-39 years
non-smoker
willing to avoid alcohol and vigorous physical activity 24 hours before visiting the lab
willing to avoid caffeine for 12 hours before visiting the lab
You may not qualify if:
Pregnant, lactating, or plans to become pregnant over the next 2 months.
Individuals who started taking medication for anxiety or depression-related symptoms within the last month.
Individuals currently taking beta-blockers or other medications/substances (marijuana and other illegal drugs) that impact heart rate.
History of reproductive disorders (e.g., premenstrual dysphoric disorder or polycystic ovary syndrome), cardiovascular (e.g., cardiac arrhythmia), or pulmonary disorders (e.g., asthma).
Pain intensity of 8 or greater in the thigh or foot in the past month
Probable alcohol use disorder
Contact the study team to confirm eligibility.
Musculoskeletal Physiological Phenomena
Musculoskeletal and Neural Physiological Phenomena
Appointments and Schedules
Organization and Administration
Health Services Administration
Primary Completion
March 31, 2023
Actual (reported)
Study Completion
March 31, 2023
Actual (reported)
Last Updated
April 18, 2023
Record last verified: 2023-04
Data Sharing
IPD Sharing
Will not share
Source record
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.